Belgium-based company Ion Beam Application (IBA) is set to install a Cyclone 30XP machine in Poland for the production of astatine-211 (At-211). At-211 is used in targeted therapies for various types of cancer, such as brain, thyroid, ovarian, breast, and prostate cancer. This installation in Poland marks IBA's third in Europe for At-211 production, with previous installations in Germany and France. In addition to At-211, IBA is also developing accelerator applications for other theranostic isotopes.
Wed, 13 Dec 2023 21:30:44 GMT | AuntMinnie